INT98951

From wiki-pain
Revision as of 02:56, 21 September 2012 by Daniel (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Context Info
Confidence 0.00
First Reported 2001
Last Reported 2001
Negated 0
Speculated 0
Reported most in Abstract
Documents 1
Total Number 1
Disease Relevance 0
Pain Relevance 0.70

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

DNA binding (NR5A2, SP3) nucleus (NR5A2, SP3) nucleoplasm (NR5A2)
intracellular (SP3) embryo development (NR5A2) cytoplasm (NR5A2)
NR5A2 (Homo sapiens)
SP3 (Homo sapiens)
Pain Link Frequency Relevance Heat
Enkephalin 1 97.64 Very High Very High Very High
mu opioid receptor 6 96.36 Very High Very High Very High
agonist 1 96.20 Very High Very High Very High
antagonist 1 93.00 High High
narcan 1 92.52 High High
Opioid 1 69.16 Quite High
Analgesic 1 60.12 Quite High
Morphine 2 59.64 Quite High

|}

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Moreover, the binding of Sp1/Sp3 to the hMOR promoter was significantly enhanced by chronic exposure to [D-Ala(2), N-Me-Phe(4), Gly(5)-ol] enkephalin (DAMGO), a selective MOR agonist, and this effect was attenuated specifically by pretreatment with a MOR antagonist, naloxone.
Positive_regulation (enhanced) of hMOR promoter Binding (binding) of Sp3 associated with antagonist, narcan, agonist, mu opioid receptor and enkephalin
1) Confidence 0.00 Published 2001 Journal Gene Section Abstract Doc Link 11675004 Disease Relevance 0 Pain Relevance 0.70

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox